MediaFierce Biotech | Prof Peter Glazer13 May 20210Fierce Biotech has reported on another of Professor Peter Glazer’s start-up ventures. Peter also has experience working with our PAT-DX1…
News UpdateBioshares | February 202123 Feb 20210Patrys was featured in the latest issue of BioShares in an article titled, “Patrys Achieves Major Development Milestone”. Read it…
News UpdateBioshares | December 202018 Dec 20200Patrys was featured in the latest issue of BioShares in an article titled, “Patrys’ PAT-DX1 Hijacks a Nucleoside Transporter to…
MediaAusBiotech Journal | Intellectual Property Feature29 Sep 20200Patrys appeared in a feature article in Ausbiotech’s journal, Australasian Biotechnology , in September 2020. The article titled, “Timing is…
News UpdateBioshares | September 202028 Sep 20200Patrys was featured in the latest issue of BioShares in an article titled, “Major Cancer Deals in DNA Damage Repair”.…
News UpdateArticle | Understanding the BBB9 Sep 20200In this article, Patrys CEO and MD Dr James Campbell compares historical access to a medieval town to the unique…
News UpdateBioshares | September 20207 Sep 20200Patrys was featured in the latest issue of BioShares in an article titled, “Janssen Shows Interest in SLE Antibodies”. Read…
NewsletterNewsletter | July 202022 Jul 20200Patrys is pleased to share its latest Newsletter, published July 2020. Key highlights: Letter From Our CEO Media and Analyst…
News UpdateBioshares | July 202020 Jul 20200Patrys was featured in the latest issue of BioShares in an article titled, “Patrys – Synthetic Lethality to Kill Cancer…
MediaHealth Kick Podcast | With Tim Boreham7 May 20200Health and Biotech expert, Tim Boreham, interviewed Patrys CEO and MD, Dr James Campbell, for the Health Kick Podcast. Listen…